Literature DB >> 16115371

Relationship between leukocyte count and angiographical characteristics of coronary atherosclerosis.

En-zhi Jia1, Zhi-jian Yang, Biao Yuan, Xiao-ling Zang, Rong-hu Wang, Tie-bing Zhu, Lian-sheng Wang, Bo Chen, Wen-zhu Ma.   

Abstract

AIM: To explore the relationship between differential leucocyte count and coronary atherosclerosis.
METHODS: The study population consisted of 507 consecutive patients (376 male and 131 female) who underwent coronary angiography for suspected or known coronary atherosclerosis. The patients' smoking and drinking habits were investigated, and anthropometric measurements, serum measurements, and hematological measurements were conducted for every patient. The severity of coronary atherosclerosis was defined by using Gensini's score system. One-way ANOVA, Spearman's correlation analysis, and multivariate stepwise linear regression analysis were employed to explore the relationship between differential leucocyte count and coronary atherosclerosis.
RESULTS: One-way ANOVA indicated that the diastolic blood pressure, glucose, urea, creatinine, leukocyte count, neutrophil count, monocyte count, hemoglobin, and platelet count differed among the groups according to Gensini's score, the tertile values of which were used as cutoff points. Spearman's correlation analysis suggested that Gensini's score was significantly correlated with age, diastolic blood pressure, glucose, urea, creatinine, leukocyte count, neutrophil count, monocyte count, hemoglobin, and erythrocyte count, respectively. Multivariate stepwise linear regression analysis show that neutrophil count (beta=0.247, P=0.000), age (beta=0.141, P=0.001), glucose (beta=0.173, P=0.000), creatinine (beta=0.088, P=0.063), hemoglobin (beta=-0.168, P=0.013) and sex (men were coded as 1 and women were coded as 2; beta=-0.121, P=0.012) were significantly independently associated with the Gensini's score.
CONCLUSION: The independent association of neutrophil count with the angiographical characteristics of coronary atherosclerosis, as estimated by Gensini's score, strongly suggests that granulocytosis may play a role in the development of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115371     DOI: 10.1111/j.1745-7254.2005.00169.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

1.  Correlations in global DNA methylation measures in peripheral blood mononuclear cells and granulocytes.

Authors:  Lissette Delgado-Cruzata; Neomi Vin-Raviv; Parisa Tehranifar; Julie Flom; Diane Reynolds; Karina Gonzalez; Regina M Santella; Mary Beth Terry
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

2.  Erythrocyte sedimentation rate as a marker for coronary heart disease.

Authors:  Josef Yayan
Journal:  Vasc Health Risk Manag       Date:  2012-04-11

3.  ESR rate can be a marker for coronary artery disease.

Authors:  Tasnim Eghbal Eftekhaari
Journal:  Vasc Health Risk Manag       Date:  2012-12-18

4.  Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: a hospital-based, prospective study in Greek patients.

Authors:  Vasileios Peppes; George Rammos; Efstathios Manios; Eleni Koroboki; Stylianos Rokas; Nikolaos Zakopoulos
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

5.  Relationship of renin-angiotensin-aldosterone system polymorphisms and phenotypes to mortality in Chinese coronary atherosclerosis patients.

Authors:  En-Zhi Jia; Zhao-Hong Chen; Feng-Hui An; Li-Hua Li; Chang-Yan Guo; Yan Gu; Zhe Liu; Zhao-Yang Li; Tie-Bing Zhu; Lian-Sheng Wang; Chun-Jian Li; Xiang-Qing Kong; Wen-Zhu Ma; Zhi-Jian Yang
Journal:  Sci Rep       Date:  2014-04-11       Impact factor: 4.379

6.  Subclinical hearing loss, longer sleep duration, and cardiometabolic risk factors in Japanese general population.

Authors:  Kei Nakajima; Eiichiro Kanda; Ami Hosobuchi; Kaname Suwa
Journal:  Int J Otolaryngol       Date:  2014-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.